Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1974339rdf:typepubmed:Citationlld:pubmed
pubmed-article:1974339lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:1974339lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:1974339lifeskim:mentionsumls-concept:C0010097lld:lifeskim
pubmed-article:1974339lifeskim:mentionsumls-concept:C0162512lld:lifeskim
pubmed-article:1974339lifeskim:mentionsumls-concept:C0005516lld:lifeskim
pubmed-article:1974339lifeskim:mentionsumls-concept:C0282151lld:lifeskim
pubmed-article:1974339lifeskim:mentionsumls-concept:C0175631lld:lifeskim
pubmed-article:1974339lifeskim:mentionsumls-concept:C0011307lld:lifeskim
pubmed-article:1974339lifeskim:mentionsumls-concept:C2827662lld:lifeskim
pubmed-article:1974339lifeskim:mentionsumls-concept:C0058123lld:lifeskim
pubmed-article:1974339pubmed:issue1lld:pubmed
pubmed-article:1974339pubmed:dateCreated1990-9-13lld:pubmed
pubmed-article:1974339pubmed:abstractText[3H]Dihydrotetrabenazine ([3H]TBZOH), a derivative of the monoamine depleting agent, tetrabenazine, has been shown to bind to the vesicular monoamine transporter. We studied the effect of unilateral nigral lesion with 6-hydroxydopamine on [3H]TBZOH binding in the striatum by means of quantitative autoradiography. Topographical analysis of striatal [3H]TBZOH binding showed in control rats a pattern similar to the known distribution of dopaminergic innervation, and allowed to visualize dopaminergic denervation in lesioned rats. A good correlation was found between striatal [3H]TBZOH binding levels and tyrosine hydroxylase activities in similar areas on adjacent slices following 6-OHDA lesions with varying severity. These data reveal that autoradiography of [3H]TBZOH binding is a good index for the visualization and quantitation of dopaminergic nerve terminals integrity in the striatum.lld:pubmed
pubmed-article:1974339pubmed:languageenglld:pubmed
pubmed-article:1974339pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1974339pubmed:citationSubsetIMlld:pubmed
pubmed-article:1974339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1974339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1974339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1974339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1974339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1974339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1974339pubmed:statusMEDLINElld:pubmed
pubmed-article:1974339pubmed:monthJunlld:pubmed
pubmed-article:1974339pubmed:issn0304-3940lld:pubmed
pubmed-article:1974339pubmed:authorpubmed-author:SchermanDDlld:pubmed
pubmed-article:1974339pubmed:authorpubmed-author:MasuiSSlld:pubmed
pubmed-article:1974339pubmed:authorpubmed-author:RostèneWWlld:pubmed
pubmed-article:1974339pubmed:authorpubmed-author:PélapratDDlld:pubmed
pubmed-article:1974339pubmed:issnTypePrintlld:pubmed
pubmed-article:1974339pubmed:day22lld:pubmed
pubmed-article:1974339pubmed:volume114lld:pubmed
pubmed-article:1974339pubmed:ownerNLMlld:pubmed
pubmed-article:1974339pubmed:authorsCompleteYlld:pubmed
pubmed-article:1974339pubmed:pagination45-50lld:pubmed
pubmed-article:1974339pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:meshHeadingpubmed-meshheading:1974339-...lld:pubmed
pubmed-article:1974339pubmed:year1990lld:pubmed
pubmed-article:1974339pubmed:articleTitle[3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum.lld:pubmed
pubmed-article:1974339pubmed:affiliationINSERM U.55, Hôpital Saint-Antoine, Paris, France.lld:pubmed
pubmed-article:1974339pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1974339pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1974339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1974339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1974339lld:pubmed